foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI: The Senolytic Peptide That

Name: foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI: The Senolytic Peptide That
Brand: skntheory.com
SKU: 8084036354
Price: 22.15 USD
Availability: InStock
Rating: 4.7488 (14 reviews)

SKU: 8084036354

4.7

USD22.15 USD72.15

Pay in 4 interest-free payments of $5.54 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness foxo4 dri senolytic peptide research Development of a novel by precise disruption of FOXO4 p53 complex FOXO4 DRI Vial 10mg Stemcode FOXO4 DRI Peptide Senolytic & Longevity Research PeptWorld foxo4 dri senolytic peptide study improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from foxo4 dri peptide senolytic skin regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI: The Senolytic Peptide That foxo4 dri peptide senolytic 2023 2024 study inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis

Store: skntheory.com · Domain: skntheory.com

Description

269 , F225F235 (1995)